المؤلفون: Meyer RJ; Office of Drug Evaluation II, Center for Drug Evaluation and Research, US Food and Drug Administration, Rockville, MD 20857, USA. meyerro@cder.fda.gov

المصدر: Annals of emergency medicine [Ann Emerg Med] 2003 Apr; Vol. 41 (4), pp. 559-60.

نوع المنشور: Comment; Journal Article

بيانات الدورية: Publisher: Mosby Country of Publication: United States NLM ID: 8002646 Publication Model: Print Cited Medium: Print ISSN: 0196-0644 (Print) Linking ISSN: 01960644 NLM ISO Abbreviation: Ann Emerg Med Subsets: MEDLINE

مواضيع طبية MeSH: Drug Labeling* , United States Food and Drug Administration*, Antiemetics/*adverse effects , Antipsychotic Agents/*adverse effects , Arrhythmias, Cardiac/*chemically induced , Droperidol/*adverse effects , Long QT Syndrome/*chemically induced, Adverse Drug Reaction Reporting Systems ; Evidence-Based Medicine ; Humans ; United States